Clinical trial
An Open-Label Pilot Study of Pioglitazone in Sporadic Inclusion Body Myositis
NCT03440034 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Pilot Study of Pioglitazone in Sporadic Inclusion Body Myositis
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 22, 2018
- Completion date
- December 31, 2020
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inclusion body myositis, muscular diseases, musculoskeletal disease, myositis, nervous system diseases, neuromuscular diseases